Thyroid disease in pregnant women with systemic lupus erythematosus: Increased preterm delivery

A. Stagnaro-Green, E. Akhter, C. Yim, Terry F. Davies, L. S. Magder, Michelle Petri

Research output: Contribution to journalArticle

Abstract

Thyroid disease is common in pregnancy and is associated with miscarriage, preterm delivery and postpartum thyroiditis (PPT). Systemic lupus erythematosus (SLE) is associated with miscarriage and preterm delivery. The hypotheses of the study are (1) pregnant women with SLE will have a high prevalence of undiagnosed hypothyroidism and a high prevalence of PPT, and (2) women with SLE and thyroid disease will have an increased incidence of adverse pregnancy outcomes as compared with pregnant women with SLE who do not have thyroid disease. This was a retrospective study of the Hopkins Lupus Cohort. All women had thyroid-stimulating hormone and thyroid antibodies assayed on frozen sera. In total, 63 pregnant women who met the ACR classification for SLE were evaluated. Outcome measures were the prevalence of thyroid disease during pregnancy and postpartum, and pregnancy outcomes. Some 13% of the women were on thyroid hormone prior to becoming pregnant, 11% were diagnosed with hypothyroidism during pregnancy, and 14% developed PPT. The prevalence of preterm delivery was 67% in women with thyroid disease and 18% in women who were thyroid disease free (p = 0.002). The presence of thyroid antibodies was not correlated with preterm delivery. Pregnant women with SLE have an increased prevalence of thyroid disease. Women with SLE and thyroid disease have an increased prevalence of preterm delivery.

Original languageEnglish (US)
Pages (from-to)690-699
Number of pages10
JournalLupus
Volume20
Issue number7
DOIs
StatePublished - Jun 2011

Fingerprint

Thyroid Diseases
Systemic Lupus Erythematosus
Pregnant Women
Postpartum Thyroiditis
Spontaneous Abortion
Pregnancy Outcome
Hypothyroidism
Pregnancy
Thyroid Gland
Antibodies
Thyrotropin
Thyroid Hormones
Postpartum Period
Retrospective Studies
Outcome Assessment (Health Care)
Incidence
Serum

Keywords

  • pregnancy
  • systemic lupus erythematosus
  • thrombosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Thyroid disease in pregnant women with systemic lupus erythematosus : Increased preterm delivery. / Stagnaro-Green, A.; Akhter, E.; Yim, C.; Davies, Terry F.; Magder, L. S.; Petri, Michelle.

In: Lupus, Vol. 20, No. 7, 06.2011, p. 690-699.

Research output: Contribution to journalArticle

Stagnaro-Green, A, Akhter, E, Yim, C, Davies, TF, Magder, LS & Petri, M 2011, 'Thyroid disease in pregnant women with systemic lupus erythematosus: Increased preterm delivery', Lupus, vol. 20, no. 7, pp. 690-699. https://doi.org/10.1177/0961203310394894
Stagnaro-Green, A. ; Akhter, E. ; Yim, C. ; Davies, Terry F. ; Magder, L. S. ; Petri, Michelle. / Thyroid disease in pregnant women with systemic lupus erythematosus : Increased preterm delivery. In: Lupus. 2011 ; Vol. 20, No. 7. pp. 690-699.
@article{a62f0269f28a45c692aef362aac700d2,
title = "Thyroid disease in pregnant women with systemic lupus erythematosus: Increased preterm delivery",
abstract = "Thyroid disease is common in pregnancy and is associated with miscarriage, preterm delivery and postpartum thyroiditis (PPT). Systemic lupus erythematosus (SLE) is associated with miscarriage and preterm delivery. The hypotheses of the study are (1) pregnant women with SLE will have a high prevalence of undiagnosed hypothyroidism and a high prevalence of PPT, and (2) women with SLE and thyroid disease will have an increased incidence of adverse pregnancy outcomes as compared with pregnant women with SLE who do not have thyroid disease. This was a retrospective study of the Hopkins Lupus Cohort. All women had thyroid-stimulating hormone and thyroid antibodies assayed on frozen sera. In total, 63 pregnant women who met the ACR classification for SLE were evaluated. Outcome measures were the prevalence of thyroid disease during pregnancy and postpartum, and pregnancy outcomes. Some 13{\%} of the women were on thyroid hormone prior to becoming pregnant, 11{\%} were diagnosed with hypothyroidism during pregnancy, and 14{\%} developed PPT. The prevalence of preterm delivery was 67{\%} in women with thyroid disease and 18{\%} in women who were thyroid disease free (p = 0.002). The presence of thyroid antibodies was not correlated with preterm delivery. Pregnant women with SLE have an increased prevalence of thyroid disease. Women with SLE and thyroid disease have an increased prevalence of preterm delivery.",
keywords = "pregnancy, systemic lupus erythematosus, thrombosis",
author = "A. Stagnaro-Green and E. Akhter and C. Yim and Davies, {Terry F.} and Magder, {L. S.} and Michelle Petri",
year = "2011",
month = "6",
doi = "10.1177/0961203310394894",
language = "English (US)",
volume = "20",
pages = "690--699",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - Thyroid disease in pregnant women with systemic lupus erythematosus

T2 - Increased preterm delivery

AU - Stagnaro-Green, A.

AU - Akhter, E.

AU - Yim, C.

AU - Davies, Terry F.

AU - Magder, L. S.

AU - Petri, Michelle

PY - 2011/6

Y1 - 2011/6

N2 - Thyroid disease is common in pregnancy and is associated with miscarriage, preterm delivery and postpartum thyroiditis (PPT). Systemic lupus erythematosus (SLE) is associated with miscarriage and preterm delivery. The hypotheses of the study are (1) pregnant women with SLE will have a high prevalence of undiagnosed hypothyroidism and a high prevalence of PPT, and (2) women with SLE and thyroid disease will have an increased incidence of adverse pregnancy outcomes as compared with pregnant women with SLE who do not have thyroid disease. This was a retrospective study of the Hopkins Lupus Cohort. All women had thyroid-stimulating hormone and thyroid antibodies assayed on frozen sera. In total, 63 pregnant women who met the ACR classification for SLE were evaluated. Outcome measures were the prevalence of thyroid disease during pregnancy and postpartum, and pregnancy outcomes. Some 13% of the women were on thyroid hormone prior to becoming pregnant, 11% were diagnosed with hypothyroidism during pregnancy, and 14% developed PPT. The prevalence of preterm delivery was 67% in women with thyroid disease and 18% in women who were thyroid disease free (p = 0.002). The presence of thyroid antibodies was not correlated with preterm delivery. Pregnant women with SLE have an increased prevalence of thyroid disease. Women with SLE and thyroid disease have an increased prevalence of preterm delivery.

AB - Thyroid disease is common in pregnancy and is associated with miscarriage, preterm delivery and postpartum thyroiditis (PPT). Systemic lupus erythematosus (SLE) is associated with miscarriage and preterm delivery. The hypotheses of the study are (1) pregnant women with SLE will have a high prevalence of undiagnosed hypothyroidism and a high prevalence of PPT, and (2) women with SLE and thyroid disease will have an increased incidence of adverse pregnancy outcomes as compared with pregnant women with SLE who do not have thyroid disease. This was a retrospective study of the Hopkins Lupus Cohort. All women had thyroid-stimulating hormone and thyroid antibodies assayed on frozen sera. In total, 63 pregnant women who met the ACR classification for SLE were evaluated. Outcome measures were the prevalence of thyroid disease during pregnancy and postpartum, and pregnancy outcomes. Some 13% of the women were on thyroid hormone prior to becoming pregnant, 11% were diagnosed with hypothyroidism during pregnancy, and 14% developed PPT. The prevalence of preterm delivery was 67% in women with thyroid disease and 18% in women who were thyroid disease free (p = 0.002). The presence of thyroid antibodies was not correlated with preterm delivery. Pregnant women with SLE have an increased prevalence of thyroid disease. Women with SLE and thyroid disease have an increased prevalence of preterm delivery.

KW - pregnancy

KW - systemic lupus erythematosus

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=79957592911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957592911&partnerID=8YFLogxK

U2 - 10.1177/0961203310394894

DO - 10.1177/0961203310394894

M3 - Article

C2 - 21436215

AN - SCOPUS:79957592911

VL - 20

SP - 690

EP - 699

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 7

ER -